ITMI930699A1 - Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale - Google Patents

Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale

Info

Publication number
ITMI930699A1
ITMI930699A1 IT000699A ITMI930699A ITMI930699A1 IT MI930699 A1 ITMI930699 A1 IT MI930699A1 IT 000699 A IT000699 A IT 000699A IT MI930699 A ITMI930699 A IT MI930699A IT MI930699 A1 ITMI930699 A1 IT MI930699A1
Authority
IT
Italy
Prior art keywords
indolate
disorders
treatment
nervous system
central nervous
Prior art date
Application number
IT000699A
Other languages
English (en)
Inventor
Franco Borsini
Ettore Giraldo
Vincenzo Martino
Carlo Maria Pellegrini
Gil Myrna Quintero
Marco Turconi
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of ITMI930699A0 publication Critical patent/ITMI930699A0/it
Priority to ITMI930699A priority Critical patent/IT1271352B/it
Priority to CN94192345A priority patent/CN1124960A/zh
Priority to SG1996002949A priority patent/SG50507A1/en
Priority to US08/530,354 priority patent/US5834493A/en
Priority to EP94913101A priority patent/EP0694033A1/en
Priority to CA002160020A priority patent/CA2160020A1/en
Priority to JP6522684A priority patent/JPH08508738A/ja
Priority to PCT/EP1994/001016 priority patent/WO1994024125A1/en
Priority to HU9502913A priority patent/HUT74090A/hu
Priority to PL94310995A priority patent/PL310995A1/xx
Priority to SK1197-95A priority patent/SK119795A3/sk
Priority to CZ952602A priority patent/CZ283398B6/cs
Priority to BR9406206A priority patent/BR9406206A/pt
Priority to NZ265055A priority patent/NZ265055A/en
Priority to AU65382/94A priority patent/AU684276B2/en
Priority to IL109234A priority patent/IL109234A/en
Priority to ZA942383A priority patent/ZA942383B/xx
Publication of ITMI930699A1 publication Critical patent/ITMI930699A1/it
Priority to BG100040A priority patent/BG100040A/bg
Priority to FI954734A priority patent/FI954734A0/fi
Priority to NO953967A priority patent/NO953967L/no
Application granted granted Critical
Publication of IT1271352B publication Critical patent/IT1271352B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
ITMI930699A 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale IT1271352B (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
SK1197-95A SK119795A3 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
BR9406206A BR9406206A (pt) 1993-04-08 1994-03-31 Derivados de indol como ligantes 5-ht1a e/ou 5-ht2
US08/530,354 US5834493A (en) 1993-04-08 1994-03-31 Indole derivatives as 5-HT1A and/or 5-HT2 ligands
EP94913101A EP0694033A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
CA002160020A CA2160020A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
JP6522684A JPH08508738A (ja) 1993-04-08 1994-03-31 ５−ｈｔ１ａ及び／又は５−ｈｔ２リガンドとしてのインドール誘導体
PCT/EP1994/001016 WO1994024125A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
HU9502913A HUT74090A (en) 1993-04-08 1994-03-31 Indole derivatives, process for producing them and pharmaceutical compositions containing them
PL94310995A PL310995A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
CN94192345A CN1124960A (zh) 1993-04-08 1994-03-31 作为5-ht/a和/或5-ht2配体的吲哚衍生物
CZ952602A CZ283398B6 (cs) 1993-04-08 1994-03-31 Indolové deriváty jako 5-HT1A a/nebo 5-HT2 ligandy
SG1996002949A SG50507A1 (en) 1993-04-08 1994-03-31 Indole derivates as 5-ht1a and/or 5-ht2 ligands
NZ265055A NZ265055A (en) 1993-04-08 1994-03-31 3-(tetra(or hexa)hydro-pyridin-3-yl-methyl)-1h-indole derivatives, compounds, preparative process and medicaments
AU65382/94A AU684276B2 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-HT1A and/or 5-HT2 ligands
IL109234A IL109234A (en) 1993-04-08 1994-04-06 History of indole, their preparation and pharmaceutical preparations containing them
ZA942383A ZA942383B (en) 1993-04-08 1994-04-07 New indole derivatives
BG100040A BG100040A (bg) 1993-04-08 1995-10-02 Индолови производни като 5-нт1а и/или 5-нт2 лиганди
FI954734A FI954734A0 (fi) 1993-04-08 1995-10-05 Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina
NO953967A NO953967L (no) 1993-04-08 1995-10-05 Indolderivater som 5-HT1A og/eller 5-HT2 ligander

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale

Publications (3)

Publication Number Publication Date
ITMI930699A0 ITMI930699A0 (it) 1993-04-08
ITMI930699A1 true ITMI930699A1 (it) 1994-10-08
IT1271352B IT1271352B (it) 1997-05-27

Family

ID=11365694

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale

Country Status (20)

Country Link
US (1) US5834493A (it)
EP (1) EP0694033A1 (it)
JP (1) JPH08508738A (it)
CN (1) CN1124960A (it)
AU (1) AU684276B2 (it)
BG (1) BG100040A (it)
BR (1) BR9406206A (it)
CA (1) CA2160020A1 (it)
CZ (1) CZ283398B6 (it)
FI (1) FI954734A0 (it)
HU (1) HUT74090A (it)
IL (1) IL109234A (it)
IT (1) IT1271352B (it)
NO (1) NO953967L (it)
NZ (1) NZ265055A (it)
PL (1) PL310995A1 (it)
SG (1) SG50507A1 (it)
SK (1) SK119795A3 (it)
WO (1) WO1994024125A1 (it)
ZA (1) ZA942383B (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
ES2213897T3 (es) * 1997-05-09 2004-09-01 H. Lundbeck A/S Metodo de fabricacion de sertindol.
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
CA2317439A1 (en) 1998-01-14 1999-07-22 Wayne J. Brouillette Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
PT1068184E (pt) * 1998-04-08 2002-12-31 Wyeth Corp Derivados n-ariloxietilamina para o tratamento de depressao
WO1999055697A1 (en) * 1998-04-29 1999-11-04 American Home Products Corporation Serotonergic agents
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
MXPA03005433A (es) 2000-12-22 2003-09-10 Wyeth Corp Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6.
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
MX339805B (es) * 2010-04-22 2016-06-10 Intra-Cellular Therapies Inc Compuestos organicos.
MX2014012374A (es) 2012-04-14 2015-04-17 Intra Cellular Therapies Inc Compuestos organicos.
EP2968320B1 (en) 2013-03-15 2020-11-11 Intra-Cellular Therapies, Inc. Organic compounds
KR102495941B1 (ko) 2013-12-03 2023-02-06 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
RU2016143091A (ru) 2014-04-04 2018-05-08 Интра-Селлулар Терапиз, Инк. Органические соединения
WO2015154025A1 (en) 2014-04-04 2015-10-08 Intra-Cellular Therapies, Inc. Organic compounds
EP3331530A4 (en) * 2015-08-03 2018-12-19 Raze Therapeutics Inc. Mthfd2 inhibitors and uses thereof
AU2017211791B2 (en) 2016-01-26 2022-01-06 Intra-Cellular Therapies, Inc. Organic compounds
DK3407889T3 (da) 2016-03-25 2021-08-09 Intra Cellular Therapies Inc Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
JP6987868B2 (ja) 2016-12-29 2022-01-05 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
WO2018175969A1 (en) 2017-03-24 2018-09-27 Intra-Cellular Therapies, Inc. Novel compositions and methods
JP7223742B2 (ja) 2017-07-26 2023-02-16 イントラ－セルラー・セラピーズ・インコーポレイテッド 有機化合物
WO2019023063A1 (en) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. ORGANIC COMPOUNDS
EP3843738A4 (en) 2018-08-31 2022-06-01 Intra-Cellular Therapies, Inc. NEW METHODS
EP3843739A4 (en) 2018-08-31 2022-06-01 Intra-Cellular Therapies, Inc. NEW METHODS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives
JP3140155B2 (ja) * 1992-03-09 2001-03-05 杏林製薬株式会社 Ｎ，ｎ’−ジ置換アミド誘導体
CA2092112A1 (en) * 1992-03-23 1993-09-24 Nobuyoshi Iwata Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use

Also Published As

Publication number Publication date
CA2160020A1 (en) 1994-10-27
BG100040A (bg) 1996-03-29
BR9406206A (pt) 1996-02-06
CZ283398B6 (cs) 1998-04-15
NO953967L (no) 1995-12-05
SK119795A3 (en) 1996-04-03
FI954734A (fi) 1995-10-05
ZA942383B (en) 1995-10-09
US5834493A (en) 1998-11-10
IL109234A0 (en) 1994-07-31
WO1994024125A1 (en) 1994-10-27
IT1271352B (it) 1997-05-27
PL310995A1 (en) 1996-01-22
HUT74090A (en) 1996-11-28
EP0694033A1 (en) 1996-01-31
FI954734A0 (fi) 1995-10-05
HU9502913D0 (en) 1995-11-28
JPH08508738A (ja) 1996-09-17
AU684276B2 (en) 1997-12-11
NZ265055A (en) 1996-09-25
NO953967D0 (no) 1995-10-05
AU6538294A (en) 1994-11-08
CN1124960A (zh) 1996-06-19
IL109234A (en) 1998-04-05
ITMI930699A0 (it) 1993-04-08
SG50507A1 (en) 1998-07-20
CZ260295A3 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
ITMI930699A1 (it) Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
FI911986A (fi) Farmaceutiska foereningar.
IS4147A (is) Aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum
DE69218621T2 (de) Endlosformular und vorrichtung zum herstellen von briefbogen davon
BR9407575A (pt) Recombinaçao il4 de anticorpos uteis no tratamento de desordens do il4
DE58906076D1 (de) Benzophenonderivate und deren Herstellung.
ATE222763T1 (de) Verwendung von imidazo-(1,2-a)-pyridin-3-acetamid-derivaten für die therapeutische behandlung von neuropsychiatrischen syndromen in zusammenhang mit störungen der nervenbahnen der basalganglien
DE68909551D1 (de) Fluessige reiniger und deren herstellungsverfahren.
DE68910523D1 (de) Trizyklische 3-oxo-propannitril-derivate und verfahren zu deren herstellung.
DE68921127D1 (de) Schienenwagen und dessen Konstruktionsverfahren.
TW282455B (it)
ATE99310T1 (de) Substituierte 1,8-naphthyridine.
ITMI931019A1 (it) Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE9313037U1 (de) Vorrichtung zum Wirbeln bzw. Schälen von Außengewinde, Schnecken und Profilen
DE69001554D1 (de) Polyzyklische verbindungen und deren herstellung.
SE8802323L (sv) 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma
ZA893606B (en) Use of diazepinones for treating disorders of the microcirculation
GB2301774B (en) Treatment of Anxiety Disorders with Piperidine Derivatives.
ZA937604B (en) 3,3-disubstituted tri and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders
IT1151791B (it) Derivati utili in terapia in particolare per la loro azione sul sistema nervoso centrale e metodo per la loro preparazione
IT9064820A0 (it) Trattamento chimico fisico delle acque di scarico dei frantoi oleari con descrizione del metodo e dell'impianto
DE3873796D1 (de) Flammenrueckschlagsicherung und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970329